角膜基质再生手术治疗晚期圆锥角膜的一年结果
这项前瞻性非随机干预病例系列纳入14例晚期圆锥角膜患者,分组植入自体脂肪来源成体干细胞(ADASc)和/或脱细胞供体人角膜基质板层。随访1年无并发症,所有患者3个月内恢复角膜透明,最佳矫正视力有不同程度提高,部分组屈光参数和角膜厚度改善。结论认为该疗法安全且中度有效。
要点
- 晚期圆锥角膜患者基质内植入自体ADASc和/或脱细胞角膜基质板层,1年随访无并发症。
- 所有患者3个月内恢复角膜透明,无视力下降,矫正远视力有提高。
- 部分组球镜和角膜前表面曲率改善,角膜像差显著改善,角膜厚度增加。
核心结论
- 基质内植入自体ADASc和脱细胞人角膜基质在1年随访中无并发症,对晚期圆锥角膜治疗中度有效。
研究设计与样本
- 前瞻性干预性非随机病例系列,连续纳入14例晚期圆锥角膜患者,分为3个实验组。
- A组植入自体ADASc alone(3×10^6细胞/1 mL,n=5);B组植入脱细胞供体120 μm厚角膜基质板层 alone(n=5);C组植入再细胞化供体板层含1×10^6自体ADASc plus 另1×10^6细胞/1 mL(n=4)。
- 自体ADASc通过择期吸脂获取,经飞秒辅助9.5 mm直径板层切开在角膜基质内植入,表面麻醉下进行,随访12个月。
主要发现
- 1年随访无并发症,所有患者3个月内恢复角膜完全透明,无患者视力下降。
- 矫正远视力分别提高0.231、0.264和0.094 Snellen行(组1、2、3)。
- 组1屈光参数总体稳定;组2和组3球镜分别改善2.35 D和0.625 D。
- 角膜前表面曲率组1稳定,组2和组3改善(平均改善2D);角膜像差显著改善。
- OCT显示中央角膜厚度平均改善14.5 μm(组1)和116.4 μm(组2和组3),组1手术层面观察到新胶原产生;共聚焦生物显微镜确认植入板层宿主再细胞化。
临床怎么用
- 对于晚期圆锥角膜,可考虑基质内植入自体ADASc和/或脱细胞人角膜基质作为再生手术选项。
- 该疗法在1年随访中表现出安全性,无并发症,且视力、屈光和角膜形态学有中度改善。
局限性
- 非随机设计,样本量小(共14例),分组不等(n=5、5、4),随访仅1年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study evaluated 1-year safety and efficacy outcomes of corneal stroma cell therapy. Therapy consisted of implanting autologous adipose-derived adult stem cells (ADASc) with or without sheets of decellularized donor human corneal stroma within the stroma of patients with advanced keratoconus. DESIGN: This was a prospective interventional non-randomized series of cases. METHODS: Fourteen consecutive patients were selected and divided into 3 experimental groups. Group A patients underwent implantation of autologous ADASc alone (3 × 106 cells/1 mL) (n = 5). Group B patients received decellularized donor 120-μm-thick corneal stroma lamina alone (n = 5). Group C patients had implantation of recellularized donor lamina with 1 × 106 autologous ADASc plus another 1 × 106 cells/1 mL at the time of the surgery (n = 4). Autologous ADASc were obtained by elective liposuction. Implantation was performed in the corneal stroma through a femtosecond-assisted 9.5-mm diameter lamellar dissection with the patient under topical anesthesia. Twelve months of follow-up data are presented. RESULTS: No complications were observed during the 1-year follow-up, and full corneal transparency was recovered within 3 months in all patients. No patient lost lines of visual acuity. Corrected distance visual acuity improved 0.231, 0.264, and 0.094 Snellen lines in groups 1, 2, and 3, respectively. In group 1, refractive parameters showed an overall stability, whereas in groups 2 and 3, sphere improved 2.35 diopter (D) and 0.625 D, respectively. Anterior keratometry remained stable (group 1) and improved in groups 2 and 3 (mean improvement of 2D). Corneal aberrometry improved significantly. In optical coherence tomography scans, corneal thickness showed a mean improvement of 14.5 μm (group 1) and 116.4 μm (groups 2 and 3) in the central thickness, and new collagen production was observed at the surgical plane (group 1). Confocal biomicroscopy confirmed the host recellularization of the implanted laminas. CONCLUSIONS: Intrastromal implantation of autologous ADASc and decellularized human corneal stroma did not show complications at 1 year of follow-up and were moderately effective for the treatment of advanced keratoconus. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.
引用
- Alió JL, Alió Del Barrio JL, El Zarif M, et al. Regenerative Surgery of the Corneal Stroma for Advanced Keratoconus: 1-Year Outcomes. Am J Ophthalmol. 2019. PMID: 30772348. doi:10.1016/j.ajo.2019.02.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。